SEARCH

SEARCH BY CITATION

References

  • Aizawa, E., Hirabayashi, Y., Iwanaga, Y., Suzuki, K., Sakurai, K., Shimoji, M., Aiba, K., Wada, T., Tooi, N., Kawase, E., Suemori, H., Nakatsuji, N. & Mitani, K. (2012) Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors. Mol. Ther. 20, 424431.
  • Asuri, P., Bartel, M.A., Vazin, T., Jang, J.H., Wong, T.B. & Schaeffer, D.V. (2011) Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells. Mol. Ther. 20, 329338.
  • Capecchi, M.R. (1989) The new mouse genetics: altering the genome by gene targeting. Trends Genet. 5, 7076.
  • Cheng, L.T., Nagata, S., Hirano, K., Yamaguchi, S., Horie, S., Ainscough, J. & Tada, T. (2012) Cure of ADPKD by selection for spontaneous genetic repair events in Pkd1-mutated iPS cells. PLoS ONE 7, e32018.
  • Christian, M., Cermak, T., Doyle, E.L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A.J. & Voytas, D.F. (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186, 757761.
  • Evans, M. (2011) Discovering pluripotency: 30 years of mouse embryonic stem cells. Nat. Rev. Mol. Cell Biol. 12, 680686.
  • Evans, M.J. & Kaufman, M.H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154156.
  • Hartlerode, A.J. & Scully, R. (2009) Mechanisms of double-strand break repair in somatic mammalian cells. Biochem. J. 423, 157168.
  • Heyer, W.D., Ehmsen, K.T. & Liu, J. (2010) Regulation of homologous recombination in eukaryotes. Annu. Rev. Genet. 44, 113139.
  • Hockemeyer, D., Soldner, F., Beard, C., et al. (2009) Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851857.
  • Hockemeyer, D., Wang, H., Kiani, S., et al. (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29, 731734.
  • Howden, S.E., Gore, A., Li, Z., et al. (2011) Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc. Natl Acad. Sci. USA 108, 65376542.
  • Ivics, Z. & Izsvák, Z. (2011) Nonviral gene delivery with the sleeping beauty transposon system. Hum. Gene Ther. 22, 10431051.
  • Jaenisch, R. & Young, R. (2008) Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567582.
  • Kasparek, T.R. & Humphrey, T.C. (2011) DNA double-strand break repair pathways, chromosomal rearrangements and cancer. Semin. Cell Dev. Biol. 22, 886897.
  • Khan, I.F., Hirata, R.K., Wang, P.R., Li, Y., Kho, J., Nelson, A., Huo, Y., Zavaljevski, M., Ware, C. & Russell, D.W. (2010) Engineering of human pluripotent stem cells by AAV-mediated gene targeting. Mol. Ther. 18, 11921199.
  • Kim, Y.G., Cha, J. & Chandrasegaran, S. (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc. Natl Acad. Sci. USA 93, 11561160.
  • Kipps, T.J. & Herzenberg, L.A. (1986) Homologous chromosome recombination generating immunoglobulin allotype and isotype switch variants. EMBO J. 5, 263268.
  • Kos, C.H. (2004) Cre/loxP system for generating tissue-specific knockout mouse models. Nutr. Rev. 62, 243246.
  • Lefebvre, L., Dionne, N., Karaskova, J., Squire, J.A. & Nagy, A. (2001) Selection for transgene homozygosity in embryonic stem cells results in extensive loss of heterozygosity. Nat. Genet., 27, 257258.
  • Liu, G.H., Suzuki, K., Qu, J., et al. (2011) Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8, 688694.
  • Lo, B. & Parham, L. (2009) Ethical issues in stem cell research. Endocr. Rev. 30, 204213.
  • Matsumura, H., Tada, M., Otsuji, T., Yasuchika, K., Nakatsuji, N., Surani, A. & Tada, T. (2007) Targeted chromosome elimination from ES-somatic hybrid cells. Nat. Methods 4, 2325.
  • Miller, J.C., Holmes, M.C., Wang, J., Guschin, D.Y., Lee, Y.L., Rupniewski, I., Beausejour, C.M., Waite, A.J., Wang, N.S., Kim, K.A., Gregory, P.D., Pabo, C.O. & Rebar, E.J. (2007) An improved zinc-finger nuclease architecture for highly specific genome editing. Nat. Biotechnol. 25, 778785.
  • Miller, J.C., Tan, S., Qiao, G., et al. (2011) A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29, 143148.
  • Mitsui, K., Suzuki, K., Aizawa, E., Kawase, E., Suemori, H., Nakatsuji, N. & Mitani, K. (2009) Gene targeting in human pluripotent stem cells with adeno-associated virus vectors. Biochem. Biophys. Res. Commun. 388, 711717.
  • Moynahan, M.E. & Jasin, M. (2010) Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat. Rev. Mol. Cell Biol. 11, 196207.
  • Muto, S., Aiba, A., Saito, Y., Nakao, K., Nakamura, K., Tomita, K., Kitamura, T., Kurabayashi, M., Nagai, R., Higashihara, E., Harris, P.C., Katsuki, M. & Horie, S. (2002) Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum. Mol. Genet. 11, 17311742.
  • Osborn, M.J., DeFeo, A.P., Blazar, B.R. & Tolar, J. (2011) Synthetic zinc finger nuclease design and rapid assembly. Hum. Gene Ther. 22, 11551165.
  • Pattanayak, V., Ramirez, C.L., Joung, J.K. & Liu, D.R. (2011) Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat. Methods 8, 765770.
  • San Filippo, J., Sung, P. & Klein, H. (2008) Mechanism of eukaryotic homologous recombination. Annu. Rev. Biochem. 77, 229257.
  • Sebastiano, V., Maeder, M.L., Angstman, J.F., Haddad, B., Khayter, C., Yeo, D.T., Goodwin, M.J., Hawkins, J.S., Ramirez, C.L., Batista, L.F.Z., Artandi, S.E., Wernig, M. & Joung, J.K. (2011) In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells 29, 17171726.
  • Soldner, F., Laganière, J., Cheng, A.W., et al. (2011) Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318331.
  • Symington, L.S. & Gautier, J. (2011) Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 45, 247271.
  • Tada, M., Takahama, Y., Abe, K., Nakatsuji, N. & Tada, T. (2001) Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol., 11, 15531558.
  • Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. & Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861872.
  • Takahashi, K. & Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663676.
  • Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S. & Jones, J.M. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 11451147.
  • Tsukiyama, T., Asano, R., Kawaguchi, T., Kim, N., Yamada, M., Minami, N., Ohinata, Y. & Imai, H. (2011) Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system. Genes Cells 16, 815825.
  • Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S. & Gregory, P.D. (2010) Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11, 636646.
  • Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J. & Campbell, K.H. (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810813.
  • Yao, Y., Nashun, B., Zhou, T., Qin, L., Qin, L., Zhao, S., Xu, J., Esteban, M.A. & Chen, X. (2011) Generation of CD34(+) Cells from CCR5-Disrupted Human Embryonic and Induced Pluripotent Stem Cells. Hum. Gene Ther. PMID: 21981760.
  • Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I. & Thomson, J.A. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 19171920.
  • Yusa, K., Rashid, S.T., Strick-Marchand, H., et al. (2011) Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478, 391394.
  • Zhou, H., Liu, Z.G., Sun, Z.W., Huang, Y. & Yu, W.Y. (2010) Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system. J. Biotechnol. 147, 122129.
  • Zou, J., Maeder, M.L., Mali, P., Pruett-Miller, S.M., Thibodeau-Beganny, S., Chou, B.K., Chen, G., Ye, Z., Park, I.H., Daley, G.Q., Porteus, M.H., Joung, J.K. & Cheng, L. (2009) Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5, 97110.
  • Zou, J., Mali, P., Huang, X., Dowey, S.N. & Cheng, L. (2011a) Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 118, 45994608.
  • Zou, J., Sweeney, C.L., Chou, B.K., Choi, U., Pan, J., Wang, H., Dowey, S.N., Cheng, L. & Malech, H.L. (2011b) Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 117, 55615572.